Clinical Trial Update: Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants [Phase 2]

View source ↗

Summary

A Phase 2 study assesses the safety and immunogenicity of a killed oral cholera vaccine in infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera
• Diarrheal Disease
• Vibrio Infections

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera, Diarrhea | Phase 2 | Status: UNKNOWN